FindTrial
Sign In

EFFECT OF DEXMEDETOMIDINE AS AN ADDITIVE IN SUBARACHNOID BLOCK FOR PREVENTION OF SHIVERING IN PATIENTS UNDERGOING ENDOSCOPIC UROLOGICAL SURGERIES

EFFICACY OF INTRATHECAL DEXMEDETOMIDINE FOR PREVENTION OF SHIVERING IN PATIENTS UNDERGOING ENDOSCOPIC UROLOGICAL SURGERIES-A PROSPECTIVE RANDOMISED DOUBLE BLINDED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030397
Enrollment
74
Registered
2021-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N210- Calculus in bladder Health Condition 3: N20- Calculus of kidney and ureter

Interventions

Intervention1: Intrathecal dexmedetomidine: 12.5mg of 0.5% Hyperbaric Bupivacaine (2.5ml) + 5ug of intrathecal Dexmedetomidine (0.05ml) Control Intervention1: Normal Saline: Group B ââ?¬â?? 12.5mg of

Sponsors

Dilakshika Letchumanan Reddiyar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective endoscopic urological surgeries 2. ASA class I, II 3. Age 18-65 years 4. Duration of surgery more than 30 minutes

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Allergy to study drug or clonidine 3. Patients on anticoagulant or bleeding disorders 4. Infection at the site of injection 5. Patients with heart diseases 6. Patients developing signs and symptoms of intraoperative sepsis

Design outcomes

Primary

MeasureTime frame
Intensity of shivering compared between the Intervention group and Control group - Crossley Maharajan ScaleTimepoint: Every 15 mins from the time of administration of intrathecal drug in subarachnoid block till the patient is shifted to ward after 1 hour of Post Anaesthesia Care unit observation after the procedure.—

Secondary

MeasureTime frame
Time to onset of Shivering from the time of administration of intrathecal drugTimepoint: Every 15 mins from the time of administration of intrathecal drug in subarachnoid block till the patient is shifted to ward after 1 hour of Post Anaesthesia Care unit observation after the procedure. ;Usage of rescue medications to control shiveringTimepoint: Every 15 mins from the time of administration of intrathecal drug in subarachnoid block till the patient is shifted to ward after 1 hour of Post Anaesthesia Care unit observation after the procedure.—

Countries

India

Contacts

Public ContactDilakshika Letchumanan Reddiyar

Sri Ramachandra Institute of higher education and research

makilandeswari@yahoo.com9840636238

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026